DD

Dattatray Dnyaneshwar Barve

Active Director Director DIN 06491626
DIN 06491626 First appointment Jun 2018 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Dattatray Dnyaneshwar Barve

Data last updated:

Dattatray Dnyaneshwar Barve is a Director at Pyxida Lifesciences Private Limited (since 2018). The company operates in Chemicals.

DIN 06491626
Primary Designation Director
Industry Chemicals
First Appointment 19 Jun 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pyxida Lifesciences Private Limited U24290MH2018PTC310946
Director19 Jun 20182018Active

Board colleagues of Dattatray Dnyaneshwar Barve

NameDINCompanyDesignation
Vivek Raut07838938Pyxida Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pyxida Lifesciences Private Limited
Premium access

Shareholding and investment profile for Dattatray Dnyaneshwar Barve

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dattatray Dnyaneshwar Barve

Dattatray Dnyaneshwar Barve currently holds 1 directorship: Pyxida Lifesciences Private Limited (Director, since 19 Jun 2018).

Dattatray Dnyaneshwar Barve was first appointed on 19 Jun 2018 as Director at Pyxida Lifesciences Private Limited.

The current boards of Dattatray Dnyaneshwar Barve's companies include Vivek Raut (Pyxida Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available